Decibel Therapeutics, Inc.

Ownership Transactions Reported by 13 Insiders

Industry
Pharmaceutical Preparations
Location
1325 Boylston Street, Suite 500, Boston, MA

There are no Buy or Sell transactions made by insiders since 12/2/2024

Decibel Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Anna Trask Chief People Officer Sep 25, 2023
Kevin F. Mclaughlin Director Sep 25, 2023
Sara Nochur Director Sep 25, 2023
Elisabeth Leiderman Chief Financial Officer Feb 25, 2022
Peter A. Thompson Director, 10%+ Owner Jun 17, 2022
Matthew C. Kapusta Director Sep 25, 2023
John Jui-Jen Lee Chief Development Officer Sep 25, 2023
James B. Murphy Interim Chief Financial Officer Exhibit Index: 24.1 Power of Attorney Oct 7, 2022
Cynthia W. Hu General Counsel Aug 16, 2021
Alison C. Finger Director Sep 25, 2023
Laurence Reid President and Chief Executive Officer, Director Sep 25, 2023
William H. Carson Director Sep 25, 2023
Neil Exter Director, 10%+ Owner Jun 17, 2022

Recent Insider Transactions by Companies or Individuals for Decibel Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.